Synthesis and evaluation of novel pyrrolidinone-based farnesyltransferase inhibitors.

被引：0

作者：

Gallicchio, SN

Beese, LS

Bell, IM

Beshore, DC

Buser-Doepner, C

Gibbs, JB

Graham, SL

Hartman, GD

Heimbrook, DC

Kassahun, K

Koblan, KS

Kohl, NE

Lobell, RB

Rodrigues, DA

Taylor, JS

Williams, TM

机构：

[1] Merck Res Labs, Dept Med Chem, W Point, PA 19486 USA

[2] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA

[3] Merck Res Labs, Canc Res, W Point, PA 19486 USA

[4] Merck Res Labs, Dept Drug Metab, W Point, PA 19486 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2001年 / 221卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

155-MEDI

引用

页码：U28 / U28

页数：1

共 50 条

[21] Synthesis and biological evaluation of novel protein kinase C (PKC) inhibitors.
Sham, KKC
Daines, RA
Kingsbury, WD
Hofmann, GA
Mattern, MR
Nambi, P
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 213 : 202 - MEDI
[22] Farnesyltransferase inhibitors. Promising new possibility for therapy of neuroblastomas?
Girgert, R
MONATSSCHRIFT KINDERHEILKUNDE, 2005, 153 (01) : 50 - 54
[23] Synthesis and antimalarial activity of novel peptidomimetic farnesyltransferase inhibitors
Pusateri, EE
Hamilton, AD
Carrico, D
Sebti, SM
Gelb, MH
Van Voorhis, WC
Hucke, O
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U113 - U113
[24] Discovery of potent and orally active farnesyltransferase (FT) inhibitors.
Tong, YS
Wang, L
Hasvold, L
Leonard, N
Li, TM
Li, Q
Wang, WB
Cohen, J
Gu, WZ
Zhang, HY
Bauch, J
Marsh, K
Rosenberg, SH
Lin, NH
Sham, HL
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U29 - U29
[25] RhoE/Rnd3 as a target of farnesyltransferase inhibitors.
Fiordalisi, JJ
Wennerberg, K
Singh, A
Der, C
Hansen, SH
Cox, AD
CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6115S - 6115S
[26] Discovery of orally active, pyrrolidinone-based progesterone receptor partial agonists
Washburn, David G.
Hoang, Tram H.
Frazee, James S.
Johnson, Latisha
Hammond, Marlys
Manns, Sharada
Madauss, Kevin P.
Williams, Shawn P.
Duraiswami, Chaya
Tran, Thuy B.
Stewart, Eugene L.
Grygielko, Eugene T.
Glace, Lindsay E.
Trizna, Walter
Nagilla, Rakesh
Bray, Jeffrey D.
Thompson, Scott K.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (16) : 4664 - 4668
[27] Design, synthesis and biological activity of novel factor Xa inhibitors. 8. Indole-based inhibitors.
Arnaiz, DO
Chou, YL
Mohan, R
Zhao, Z
Liang, A
Trinh, L
Hinchman, J
Post, J
Shaw, KJ
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 215 : U898 - U898
[28] Synthesis and evaluation of a novel series of phosphodiesterase IV inhibitors. A potential treatment for asthma
Beasley, SC
Cooper, N
Gowers, L
Gregory, JP
Haughan, AF
Hellewell, PG
Macari, D
Miotla, J
Montana, JG
Morgan, T
Naylor, R
Runcie, KA
Tuladhar, B
Warneck, JBH
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (19) : 2629 - 2634
[29] Enantiospecific synthesis of novel analogs of glycosidase inhibitors.
Blanco, MJ
Sardina, FJ
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 213 : 105 - ORGN
[30] Design, synthesis, and evaluation of conjugated C-glycosides as novel glycosidase inhibitors.
Lin, CH
Yang, WB
Wu, CY
Chang, CC
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U167 - U167

← 1 2 3 4 5 →